0 CHECKOUT

PRODUCT FILTERS

CATEGORIES

  • 1

PRICE

0
0
0
1

PUBLISHED

0
0
0
1

PRODUCT TYPE

Search for: "Harrisburg, PA Market Overview"

Hepatitis C: Game changing regimens to revolutionise treatment landscape - KOL Insight

The December 2013 approval of Gilead's once daily oral nucleotide inhibitor Sovaldi marks a significant step in the treatment of hepatitis C (HCV) With efficacy over 90% in GT1/2/3/4 patients, this...

Published:  December 2013
Price:  From
Loading Indicator

Our Clients

  • Dow Chemical Co Ltd.
  • The Estee Lauder Companies Inc
  • Carrefour S.A.
  • Motorola Solutions, Inc.
  • Activision Publishing, Inc.
  • 3M Company